Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6450
+0.0450 (7.50%)
Aug 12, 2025, 2:44 PM EDT
Akoya Biosciences Market Cap
BCLI has a market cap or net worth of $6.63 million as of August 12, 2025. Its market cap has decreased by -77.23% in one year.
Market Cap
6.63M
Enterprise Value
6.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since May 28, 2003, BCLI's market cap has increased from 454.50K to 6.63M, an increase of 1,359.18%. That is a compound annual growth rate of 12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 6.63M | -48.78% |
| Dec 31, 2024 | 12.95M | -3.18% |
| Dec 29, 2023 | 13.37M | -77.69% |
| Dec 30, 2022 | 59.93M | -58.70% |
| Dec 31, 2021 | 145.11M | 1.59% |
| Dec 31, 2020 | 142.84M | 47.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 367.14M |
| CytoDyn | 300.75M |